SCHEMBL4132595

SCHEMBL4132595

COc1c(Cl)cc(O)cc1C(=O)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.42
CYP3A4 P08684 2/20 0.41
MAPT P10636 1/20 0.41
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
HPGD P15428 3/20 0.37
HTT P42858 2/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
FFAR1 O14842 1/20 0.34
MAPK1 P28482 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
TAS1R2 Q8TE23 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119971 0.81 ALDH1A1 (0.49) TPMTCYP3A4MAPTALDH1A1KDM4E
SCHEMBL24516637 0.79 GALK1 (0.50) TPMTMAPTALDH1A1KDM4EGAA
SCHEMBL4120602 0.79 FFAR1 (0.42) CYP3A4ALDH1A1KDM4EGAAHPGD
SCHEMBL8720641 0.75 TDP1 (0.56) TPMTCYP3A4MAPTALDH1A1KDM4E
SCHEMBL4125864 0.74 TPMT (0.41) TPMTCYP3A4MAPTALDH1A1KDM4E
SCHEMBL2388019 0.72 CYP3A4 (0.71) TPMTCYP3A4MAPTALDH1A1TDP1
SCHEMBL4125338 0.72 HTT (0.39) TPMTALDH1A1KDM4EGAAHTT
SCHEMBL12438177 0.72 HSD17B10 (0.45) CYP3A4MAPTALDH1A1KDM4EGAA
SCHEMBL4132557 0.71 TAS1R3 (0.41) TPMTALDH1A1KDM4ELMNAKMT2A
SCHEMBL4121477 0.70 AKR1C2 (0.40) CYP3A4MAPTKDM4EHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221596-A1 Substtituted aryl oximes BAYER CROPSCIENCE AG (DE) 2009-09-03 US disclosed
US-20090221596-A1 Substtituted aryl oximes BAYER CROPSCIENCE AG (DE) 2009-09-03 US disclosed
US-20090221596-A1 Substtituted aryl oximes BAYER CROPSCIENCE AG (DE) 2009-09-03 US disclosed
EP-1883622-A1 SUBSTITUTED ARYL OXIMES Bayer CropScience Aktiengesellschaft (DE) 2008-02-06 EP disclosed
WO-2007090434-A1 SUBSTITUTED ARYL OXIMES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221596-A1 Substtituted aryl oximes CYP1A1, PRDX1, CYP1A2 TPMT 4493/4885CYP3A4 84/4885MAPT 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.